Global β-Nicotinamide Mononucleotide (NMN) Market Insights and Forecast to 2028

Report ID: 1227582 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 β-Nicotinamide Mononucleotide (NMN) Product Introduction
    1.2 Market by Content
        1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Content, 2017 VS 2021 VS 2028
        1.2.2 Above 98%
        1.2.3 Below 98%
    1.3 Market by Application
        1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Application, 2017 VS 2021 VS 2028
        1.3.2 Health Care Products
        1.3.3 Cosmetics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global β-Nicotinamide Mononucleotide (NMN) Production
    2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (2017-2028)
    2.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2017 VS 2021 VS 2028
    2.3 Global β-Nicotinamide Mononucleotide (NMN) Production by Region
        2.3.1 Global β-Nicotinamide Mononucleotide (NMN) Historic Production by Region (2017-2022)
        2.3.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Production by Region (2023-2028)
    2.4 China
    2.5 Japan
    2.6 US
3 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume & Value Estimates and Forecasts
    3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028
    3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028
    3.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2021 VS 2028
    3.4 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region
        3.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022)
        3.4.2 Global Sales β-Nicotinamide Mononucleotide (NMN) by Region (2023-2028)
    3.5 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region
        3.5.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022)
        3.5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028)
    3.6 North America
    3.7 Europe
    3.8 Asia-Pacific
    3.9 Latin America
    3.10 Middle East & Africa
4 Competition by Manufactures
    4.1 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Manufacturers
    4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers
        4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2017-2022)
        4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2017-2022)
        4.2.3 Global Top 10 and Top 5 Largest Manufacturers of β-Nicotinamide Mononucleotide (NMN) in 2021
    4.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers
        4.3.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2017-2022)
        4.3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2017-2022)
        4.3.3 Global Top 10 and Top 5 Companies by β-Nicotinamide Mononucleotide (NMN) Revenue in 2021
    4.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers
    4.5 Analysis of Competitive Landscape
        4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        4.5.2 Global β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        4.5.3 Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution
    4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Content
    5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Content
        5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Historical Sales by Content (2017-2022)
        5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Content (2023-2028)
        5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content
        5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Historical Revenue by Content (2017-2022)
        5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Content (2023-2028)
        5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    5.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Content
        5.3.1 Global β-Nicotinamide Mononucleotide (NMN) Price by Content (2017-2022)
        5.3.2 Global β-Nicotinamide Mononucleotide (NMN) Price Forecast by Content (2023-2028)
6 Market Size by Application
    6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales by Application
        6.1.1 Global β-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022)
        6.1.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028)
        6.1.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    6.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application
        6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022)
        6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028)
        6.2.3 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application
        6.3.1 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022)
        6.3.2 Global β-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028)
7 North America
    7.1 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Content
        7.1.1 North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
        7.1.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2028)
    7.2 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Application
        7.2.1 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
        7.2.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
    7.3 North America β-Nicotinamide Mononucleotide (NMN) Sales by Country
        7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028)
        7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
        7.3.3 United States
        7.3.4 Canada
8 Europe
    8.1 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Content
        8.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
        8.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2028)
    8.2 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Application
        8.2.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
        8.2.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
    8.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country
        8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028)
        8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
        8.3.3 Germany
        8.3.4 France
        8.3.5 U.K.
        8.3.6 Italy
        8.3.7 Russia
9 Asia Pacific
    9.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Content
        9.1.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
        9.1.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2028)
    9.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Application
        9.2.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
        9.2.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
    9.3 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region
        9.3.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028)
        9.3.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028)
        9.3.3 China
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 India
        9.3.7 Australia
        9.3.8 China Taiwan
        9.3.9 Indonesia
        9.3.10 Thailand
        9.3.11 Malaysia
10 Latin America
    10.1 Latin America β-Nicotinamide Mononucleotide (NMN) Market Size by Content
        10.1.1 Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
        10.1.2 Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2028)
    10.2 Latin America β-Nicotinamide Mononucleotide (NMN) Market Size by Application
        10.2.1 Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
        10.2.2 Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
    10.3 Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Country
        10.3.1 Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028)
        10.3.2 Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
        10.3.3 Mexico
        10.3.4 Brazil
        10.3.5 Argentina
        10.3.6 Colombia
11 Middle East and Africa
    11.1 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Content
        11.1.1 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2028)
        11.1.2 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2028)
    11.2 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Application
        11.2.1 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028)
        11.2.2 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028)
    11.3 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country
        11.3.1 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028)
        11.3.2 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028)
        11.3.3 Turkey
        11.3.4 Saudi Arabia
        11.3.5 UAE
12 Corporate Profiles
    12.1 GeneHarbor
        12.1.1 GeneHarbor Corporation Information
        12.1.2 GeneHarbor Overview
        12.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.1.5 GeneHarbor Recent Developments
    12.2 Herbalmax
        12.2.1 Herbalmax Corporation Information
        12.2.2 Herbalmax Overview
        12.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.2.5 Herbalmax Recent Developments
    12.3 Genex Formulas
        12.3.1 Genex Formulas Corporation Information
        12.3.2 Genex Formulas Overview
        12.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.3.5 Genex Formulas Recent Developments
    12.4 Shinkowa Pharmaceutical
        12.4.1 Shinkowa Pharmaceutical Corporation Information
        12.4.2 Shinkowa Pharmaceutical Overview
        12.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.4.5 Shinkowa Pharmaceutical Recent Developments
    12.5 Maac10 Formulas
        12.5.1 Maac10 Formulas Corporation Information
        12.5.2 Maac10 Formulas Overview
        12.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.5.5 Maac10 Formulas Recent Developments
    12.6 EffePharm
        12.6.1 EffePharm Corporation Information
        12.6.2 EffePharm Overview
        12.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.6.5 EffePharm Recent Developments
    12.7 Bontac
        12.7.1 Bontac Corporation Information
        12.7.2 Bontac Overview
        12.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.7.5 Bontac Recent Developments
    12.8 CELFULL
        12.8.1 CELFULL Corporation Information
        12.8.2 CELFULL Overview
        12.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.8.5 CELFULL Recent Developments
    12.9 Kingdomway
        12.9.1 Kingdomway Corporation Information
        12.9.2 Kingdomway Overview
        12.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022)
        12.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
        12.9.5 Kingdomway Recent Developments
13 Industry Chain and Sales Channels Analysis
    13.1 β-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
    13.2 β-Nicotinamide Mononucleotide (NMN) Key Raw Materials
        13.2.1 Key Raw Materials
        13.2.2 Raw Materials Key Suppliers
    13.3 β-Nicotinamide Mononucleotide (NMN) Production Mode & Process
    13.4 β-Nicotinamide Mononucleotide (NMN) Sales and Marketing
        13.4.1 β-Nicotinamide Mononucleotide (NMN) Sales Channels
        13.4.2 β-Nicotinamide Mononucleotide (NMN) Distributors
    13.5 β-Nicotinamide Mononucleotide (NMN) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    14.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
    14.2 β-Nicotinamide Mononucleotide (NMN) Market Drivers
    14.3 β-Nicotinamide Mononucleotide (NMN) Market Challenges
    14.4 β-Nicotinamide Mononucleotide (NMN) Market Restraints
15 Key Finding in The Global β-Nicotinamide Mononucleotide (NMN) Study
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Content, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Above 98%
    Table 3. Major Manufacturers of Below 98%
    Table 4. Global β-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
    Table 5. Global β-Nicotinamide Mononucleotide (NMN) Production by Region: 2017 VS 2021 VS 2028 (Kg)
    Table 6. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2017-2022) & (Kg)
    Table 7. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2017-2022)
    Table 8. Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2023-2028) & (Kg)
    Table 9. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2023-2028)
    Table 10. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
    Table 12. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2022)
    Table 13. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
    Table 14. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2023-2028)
    Table 15. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2022)
    Table 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2023-2028)
    Table 19. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Manufacturers (2017-2022) & (Kg)
    Table 20. Global β-Nicotinamide Mononucleotide (NMN) Capacity Market Share by Manufacturers (2017-2022)
    Table 21. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2017-2022) & (Kg)
    Table 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2017-2022)
    Table 23. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers (2017-2022)
    Table 25. β-Nicotinamide Mononucleotide (NMN) Price by Manufacturers 2017-2022 (US$/Kg)
    Table 26. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global β-Nicotinamide Mononucleotide (NMN) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Nicotinamide Mononucleotide (NMN) as of 2021)
    Table 28. β-Nicotinamide Mononucleotide (NMN) Manufacturing Base Distribution and Headquarters
    Table 29. Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Offered
    Table 30. Date of Manufacturers Enter into β-Nicotinamide Mononucleotide (NMN) Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
    Table 33. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
    Table 34. Global β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2017-2022)
    Table 35. Global β-Nicotinamide Mononucleotide (NMN) Sales Share by Content (2023-2028)
    Table 36. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (US$ Million)
    Table 37. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (US$ Million)
    Table 38. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2017-2022)
    Table 39. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Content (2023-2028)
    Table 40. β-Nicotinamide Mononucleotide (NMN) Price by Content (2017-2022) & (US$/Kg)
    Table 41. Global β-Nicotinamide Mononucleotide (NMN) Price Forecast by Content (2023-2028) & (US$/Kg)
    Table 42. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
    Table 43. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
    Table 44. Global β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2017-2022)
    Table 45. Global β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2023-2028)
    Table 46. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million)
    Table 48. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2017-2022)
    Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2023-2028)
    Table 50. β-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) & (US$/Kg)
    Table 51. Global β-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) & (US$/Kg)
    Table 52. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
    Table 53. North America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
    Table 54. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (US$ Million)
    Table 55. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (US$ Million)
    Table 56. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
    Table 57. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
    Table 58. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million)
    Table 59. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million)
    Table 60. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
    Table 61. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
    Table 62. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million)
    Table 63. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million)
    Table 64. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
    Table 65. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
    Table 66. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (US$ Million)
    Table 67. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (US$ Million)
    Table 68. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
    Table 69. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
    Table 70. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million)
    Table 71. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million)
    Table 72. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
    Table 73. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
    Table 74. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million)
    Table 75. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million)
    Table 76. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
    Table 77. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
    Table 78. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (US$ Million)
    Table 79. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (US$ Million)
    Table 80. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
    Table 81. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
    Table 82. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million)
    Table 83. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million)
    Table 84. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
    Table 85. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg)
    Table 86. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (US$ Million)
    Table 87. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (US$ Million)
    Table 88. Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
    Table 89. Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
    Table 90. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (US$ Million)
    Table 91. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (US$ Million)
    Table 92. Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
    Table 93. Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
    Table 94. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
    Table 97. Latin America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
    Table 98. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million)
    Table 99. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
    Table 101. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2023-2028) & (Kg)
    Table 102. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
    Table 105. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg)
    Table 106. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million)
    Table 108. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
    Table 109. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg)
    Table 110. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million)
    Table 112. GeneHarbor Corporation Information
    Table 113. GeneHarbor Description and Major Businesses
    Table 114. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 115. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. GeneHarbor Recent Development
    Table 117. Herbalmax Corporation Information
    Table 118. Herbalmax Description and Major Businesses
    Table 119. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 120. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Herbalmax Recent Development
    Table 122. Genex Formulas Corporation Information
    Table 123. Genex Formulas Description and Major Businesses
    Table 124. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 125. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Genex Formulas Recent Development
    Table 127. Shinkowa Pharmaceutical Corporation Information
    Table 128. Shinkowa Pharmaceutical Description and Major Businesses
    Table 129. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 130. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Shinkowa Pharmaceutical Recent Development
    Table 132. Maac10 Formulas Corporation Information
    Table 133. Maac10 Formulas Description and Major Businesses
    Table 134. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 135. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Maac10 Formulas Recent Development
    Table 137. EffePharm Corporation Information
    Table 138. EffePharm Description and Major Businesses
    Table 139. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 140. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. EffePharm Recent Development
    Table 142. Bontac Corporation Information
    Table 143. Bontac Description and Major Businesses
    Table 144. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 145. Bontac β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Bontac Recent Development
    Table 147. CELFULL Corporation Information
    Table 148. CELFULL Description and Major Businesses
    Table 149. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 150. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. CELFULL Recent Development
    Table 152. Kingdomway Corporation Information
    Table 153. Kingdomway Description and Major Businesses
    Table 154. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 155. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Kingdomway Recent Development
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. β-Nicotinamide Mononucleotide (NMN) Distributors List
    Table 160. β-Nicotinamide Mononucleotide (NMN) Customers List
    Table 161. β-Nicotinamide Mononucleotide (NMN) Market Trends
    Table 162. β-Nicotinamide Mononucleotide (NMN) Market Drivers
    Table 163. β-Nicotinamide Mononucleotide (NMN) Market Challenges
    Table 164. β-Nicotinamide Mononucleotide (NMN) Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Picture
    Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Share by Content in 2021 & 2028
    Figure 3. Above 98% Product Picture
    Figure 4. Below 98% Product Picture
    Figure 5. Global β-Nicotinamide Mononucleotide (NMN) Market Share by Application in 2021 & 2028
    Figure 6. Health Care Products
    Figure 7. Cosmetics
    Figure 8. Others
    Figure 9. β-Nicotinamide Mononucleotide (NMN) Report Years Considered
    Figure 10. Global β-Nicotinamide Mononucleotide (NMN) Capacity, Production and Utilization (2017-2028) & (Kg)
    Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region in Percentage: 2021 Versus 2028
    Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2017-2022)
    Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2023-2028)
    Figure 14. β-Nicotinamide Mononucleotide (NMN) Production Growth Rate in China (2017-2028) & (Kg)
    Figure 15. β-Nicotinamide Mononucleotide (NMN) Production Growth Rate in Japan (2017-2028) & (Kg)
    Figure 16. β-Nicotinamide Mononucleotide (NMN) Production Growth Rate in US (2017-2028) & (Kg)
    Figure 17. Global β-Nicotinamide Mononucleotide (NMN) Sales 2017-2028 (Kg)
    Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue 2017-2028 (US$ Million)
    Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2022)
    Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2023-2028)
    Figure 23. North America β-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg)
    Figure 24. North America β-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Europe β-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg)
    Figure 26. Europe β-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg)
    Figure 28. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Latin America β-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg)
    Figure 30. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg)
    Figure 32. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. The β-Nicotinamide Mononucleotide (NMN) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 34. The Top 5 and 10 Largest Manufacturers of β-Nicotinamide Mononucleotide (NMN) in the World: Market Share by β-Nicotinamide Mononucleotide (NMN) Revenue in 2021
    Figure 35. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 36. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    Figure 37. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    Figure 38. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    Figure 39. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    Figure 40. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    Figure 41. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    Figure 42. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    Figure 43. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    Figure 44. North America β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028)
    Figure 45. North America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028)
    Figure 46. United States β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 47. Canada β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 48. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    Figure 49. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    Figure 50. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    Figure 51. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    Figure 52. Europe β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028)
    Figure 53. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028)
    Figure 54. Germany β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 55. France β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 56. U.K. β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 57. Italy β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 58. Russia β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 59. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    Figure 60. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    Figure 61. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    Figure 62. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    Figure 63. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Share by Region (2017-2028)
    Figure 64. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Revenue Share by Region (2017-2028)
    Figure 65. China β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 66. Japan β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 67. South Korea β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 68. India β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 69. Australia β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 70. China Taiwan β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 71. Indonesia β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 72. Thailand β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 73. Malaysia β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    Figure 75. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    Figure 76. Latin America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    Figure 77. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028)
    Figure 79. Latin America β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028)
    Figure 80. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 83. Colombia β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2028)
    Figure 85. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2028)
    Figure 86. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028)
    Figure 90. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 92. UAE β-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million)
    Figure 93. β-Nicotinamide Mononucleotide (NMN) Value Chain
    Figure 94. β-Nicotinamide Mononucleotide (NMN) Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Frequently Asked Questions
β-Nicotinamide Mononucleotide (NMN) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
β-Nicotinamide Mononucleotide (NMN) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
β-Nicotinamide Mononucleotide (NMN) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Tray Sealers

Medical Tray Sealers market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Round Knitting Looms

Round Knitting Looms market is segmented by Size and by Application. Players, stakeholders, and o ... Read More

Copper Scrap

Copper Scrap market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More